Total Payments
$347,072
2024 Payments
$19,141
Companies
18
Transactions
576
Medicare Patients
421
Medicare Billing
$114,841
Payment Breakdown by Category
Other$227,113 (65.4%)
Consulting$76,542 (22.1%)
Travel$30,563 (8.8%)
Food & Beverage$12,566 (3.6%)
Education$287.87 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $197,975 | 101 | 57.0% |
| Consulting Fee | $76,542 | 30 | 22.1% |
| Travel and Lodging | $30,563 | 108 | 8.8% |
| Honoraria | $29,138 | 17 | 8.4% |
| Food and Beverage | $12,566 | 313 | 3.6% |
| Education | $287.87 | 7 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $73,642 | 130 | $0 (2022) |
| ABBVIE INC. | $66,479 | 127 | $0 (2024) |
| Amgen Inc. | $61,134 | 65 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $51,622 | 159 | $0 (2021) |
| Lundbeck LLC | $36,455 | 27 | $0 (2024) |
| Lilly USA, LLC | $26,198 | 24 | $0 (2022) |
| IMPEL PHARMACEUTICALS INC. | $15,665 | 11 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $5,226 | 7 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $3,618 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $2,432 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,141 | 37 | ABBVIE INC. ($17,202) |
| 2023 | $30,682 | 46 | AbbVie Inc. ($23,264) |
| 2022 | $39,465 | 52 | Lundbeck LLC ($15,758) |
| 2021 | $47,087 | 72 | AbbVie Inc. ($22,441) |
| 2020 | $23,826 | 56 | Allergan, Inc. ($18,088) |
| 2019 | $45,578 | 74 | Amgen Inc. ($23,255) |
| 2018 | $75,890 | 114 | Allergan Inc. ($24,436) |
| 2017 | $65,402 | 125 | Supernus Pharmaceuticals, Inc. ($30,460) |
All Payment Transactions
576 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | Lundbeck LLC | VYEPTI (Biological) | Consulting Fee | Cash or cash equivalent | $1,293.75 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $92.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $0.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Consulting Fee | Cash or cash equivalent | $126.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 08/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $46.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 157 | 214 | $82,041 | $24,006 |
| 2022 | 2 | 34 | 35 | $9,675 | $3,585 |
| 2021 | 6 | 136 | 5,826 | $109,220 | $47,346 |
| 2020 | 5 | 94 | 5,911 | $100,081 | $39,903 |
Total Patients
421
Total Services
11,986
Medicare Billing
$114,841
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 50 | 60 | $23,310 | $7,446 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $20,513 | $5,983 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 58 | $16,748 | $4,850 | 29.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 11 | 29 | $12,968 | $3,301 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,874 | $1,309 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 19 | $3,629 | $1,118 | 30.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 17 | $5,355 | $2,176 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 18 | $4,320 | $1,409 | 32.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 15 | 5,665 | $57,526 | $27,480 | 47.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 31 | 41 | $12,915 | $5,591 | 43.3% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 17 | 35 | $14,686 | $4,953 | 33.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 49 | $11,760 | $4,768 | 40.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $9,443 | $3,330 | 35.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 17 | $2,890 | $1,224 | 42.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 16 | 5,800 | $58,754 | $28,166 | 47.9% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 17 | 33 | $13,530 | $4,612 | 34.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 28 | 33 | $10,395 | $3,616 | 34.8% |
| 64405 | Injection of anesthetic agent and/or steroid into greater occipital nerve of upper neck and back of head | Office | 2020 | 13 | 21 | $11,642 | $1,899 | 16.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 24 | $5,760 | $1,611 | 28.0% |
About Dr. John Rothrock, MD
Dr. John Rothrock, MD is a Neurology healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174577449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Rothrock, MD has received a total of $347,072 in payments from pharmaceutical and medical device companies, with $19,141 received in 2024. These payments were reported across 576 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($197,975).
As a Medicare-enrolled provider, Rothrock has provided services to 421 Medicare beneficiaries, totaling 11,986 services with total Medicare billing of $114,841. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Fairfax, VA
- Active Since 05/20/2006
- Last Updated 09/05/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1174577449
Products in Payments
- TROKENDI XR (Drug) $51,263
- BOTOX (Biological) $45,060
- Aimovig (Biological) $40,446
- UBRELVY (Drug) $39,357
- VYEPTI (Biological) $36,455
- QULIPTA (Drug) $30,608
- Trudhesa (Drug) $15,665
- BOTOX (Drug) $13,822
- NURTEC ODT (Drug) $9,003
- BOTOX THERAPEUTIC (Biological) $4,739
- AIMOVIG (Biological) $2,421
- ONZETRA Xsail (Drug) $2,318
- BOTOX-NEUROLOGY (Drug) $1,955
- Zembrace (Drug) $1,000
- ZEMBRACE SYMTOUCH (Drug) $516.73
- BOTOX CHRONIC MIGRAINE (Drug) $442.44
- OXTELLAR XR (Drug) $359.60
- GAMMAGARD (Biological) $26.28
- EMBOLD Fibered (Device) $19.64
- EMGALITY (Drug) $13.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Fairfax
Dr. Rahul Dave, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $405,192
Neurology $405,192
Laura Cinski, M.d, M.D
Neurology — Payments: $70,544
Neurology $70,544
Abigail Lawler, M.d, M.D
Neurology — Payments: $45,925
Neurology $45,925
Dr. David Whitney, M.d, M.D
Neurology — Payments: $35,830
Neurology $35,830
Dr. Amy Safadi, Md, MD
Neurology — Payments: $22,090
Neurology $22,090
Hannah Irving, Md, MD
Neurology — Payments: $6,570
Neurology $6,570